Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
N/A N=72 Randomized Double-blind Prevention

Exercise for Low Back Pain in Children

Low Back Pain

Bottom Line

View on ClinicalTrials.gov: NCT00786864 ↗
Enrolled (actual)
72
Serious AEs
—
Results posted
Nov 2008
Primary outcome: Primary: Low Back Pain Prevalence — 16; 26 participants — p=p=0.001

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
exercise programme (Other)
Age
Pediatric · 12+ yrs
Sex
All
Sponsor
University of Witwatersrand, South Africa
Primary completion
Oct 2007

Outcome Measures

OutcomeResultp-value
PRIMARY
Low Back Pain Prevalence		 16; 26 p=0.001 sig
PRIMARY
Low Back Pain Intensity		 1.76; 3.73 p<0.001 sig
SECONDARY
Neural Mobility		 64.41; 44.44 p<0.001 sig
SECONDARY
Hamstring Flexibility		 54.00; 45.76 p<0.01 sig

Summary

This study aimed to determine the efficacy of an eight-week specific exercise programme in reducing self-reported episodes and intensity of LBP, as well as modifying some of the identified risk factors for LBP, in children.

Eligibility Criteria

Inclusion Criteria

  • Children aged 12-13 years
  • Complained of LBP in the past three months

Exclusion Criteria

  • Serious spinal pathologies or deformities (e.g. severe scoliosis, spinal tumours)
  • Neurological conditions which alter motor tone
  • Physical disabilities (e.g. spinal cord injuries) which prevent the child from being able to stand up on their own without an orthotic device or brace, or which prevent the child from taking part in normal physical education (PE) classes
  • Any other serious co-morbidities (e.g. cancer, severe lung pathology)
  • Provincial sports participants, or children who were currently following a specific training programme with a biokineticist or physiotherapist
  • Current orthopaedic procedures or fractures of the spine, pelvis, lower or upper limbs
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT00786864). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search